Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Annual gross margin of global top 25 pharmas in 2014
View:
Post by rgonlyfactspls on Nov 01, 2015 11:51am

Annual gross margin of global top 25 pharmas in 2014

Several big name pharmas with a strategic focus on cancer treatments and oncology in particular, are below the "AVERAGE" gross margin level of these 25 pharmas that made the list. Surely Telesta, with MCNA at a margin level of 90-95%, will be like a drug they must have (once/if MCNA approved by FDA). How could they tell their shareholders they did not seriously consider acquiring Telesta???...unless Tele$ta becomes too pricey very quickly. GLTA --- https://www.statista.com/statistics/473429/top-global-pharmaceutical-companies-gross-margin-values/ --- Also, see second link for additional info relating to large biotechs' gross margin levels in Q1-15 --- https://www.statista.com/statistics/274572/gross-profit-margin-of-united-states-biotech-companies/
Comment by RetailRube on Nov 01, 2015 1:49pm
90-95% gross margin sounds quite high considering we have to pay Endo a 5% royalty on global revenue.  Margin will be high, but I will believe it when the company discloses it in writing, or I can analyse the actual results when they have revenue.  Which could be soon.
Comment by RetailRube on Nov 01, 2015 1:53pm
Nonetheless, RGFacts, I rated your post a 5.  Thanks for contacting the analyst and letting us know what he said.
Comment by txbioinv on Nov 02, 2015 10:52am
Fortunately, there is a cap on the Endo deal............cannot remember exactly if its a time frame from when commercialization commences and/or a specific dollar amount, 10 yrs I believe. Its not forever. I wish we would do our own investigation why MCNA was in a Phase 3b that virtually was impossible to conduct; I would start with ex leadership that's been ousted ..........scuuumbaags. GL ...more  
Comment by 13PunterDog on Nov 02, 2015 11:34am
I can confirm it's 10 years from first sales. I looked at it last night in the news section of Stockhouse, the 7th or 8th page I believe. Yes they railroaded us with one big railway tie up our azz in the Phase III B.Scumbags is a rather milder term I would use. Also , Paladin ( now Endo who bought them ) has royalties ( 5% ? ) for Canada, Mexico, and South Africa, don't forget. Thus they ...more  
Comment by cheetio on Nov 02, 2015 12:55pm
Does anyone think that this management team would split 15:1 before ADComm meeting........ha.......watch and see
Comment by DryBones on Nov 02, 2015 4:22pm
Punter.  If I was management at TST, I would llft a finger to getting mcna approved in Endo's market area:  Canada, South Africa and Mexico.  Let Endo come back to the table and beg.
Comment by 13PunterDog on Nov 02, 2015 6:12pm
Actually Art, I totally agree with you , to he!! with Canada, South Africa and Mexico for MCNA. I'll just have to go to the South of France for my treatment in 25 years after all the tax free money I make from this. Could go to the States, but been there a few times too many. I was just trying to put it in a more nice way so someone doesn't freak out  on me not wanting it for Canada. ...more  
Comment by txbioinv on Nov 02, 2015 4:49pm
Punter, thanks for confirming the 10 years, much appreciated. I still believe old bioniche leadership and old endo leadership were 'on the same page' if you know what I mean....................GL longtimers
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities